Northern Star Resources (ASX:NST) wrapped up its $6 billion takeover of developer De Grey Mining (ASX:DEG) earlier this month ...

As Nanosonics scores FDA De Novo win, investors are now watching EMVision’s brain scanner in its US trials with Mayo Clinic.

ASX biotechs have become well-known for paediatric drug discovery with several life-altering treatments exported to the world.